With AI and massive profits at stake, Silicon Valley executives have shown that they are unwilling to mitigate its dangers.
A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results